Safety and Effectiveness of Dapoxetine On Demand in Chinese Men With Premature Ejaculation: Results of a Multicenter, Prospective, Open-Label Phase IV Study
Introduction: Dapoxetine on demand has been approved for premature ejaculation (PE) management in China; however, studies on the efficacy and safety of this treatment in the Chinese population are scarce. Aim: The aim of this study was to evaluate the safety and effectiveness of dapoxetine 30 mg and...
Main Authors: | Jing Peng, MD, Lin Yang, MD, Long Liu, MD, Renyuan Zhou, MD, Jihong Liu, MD, Ningchen Li, MD, Liming Li, MD, Yongguang Jiang, MD, Yuqiang Liu, MD, Zhaohui Zhu, MD, Xiaodong Zhang, MD, Guowei Shi, MD, Suyog Jain, MD, Emmanuele A. Jannini, MD, Zhichao Zhang, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2021-04-01
|
Series: | Sexual Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2050116120301835 |
Similar Items
-
The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy: The PASSION Study
by: Chris McMahon, MBBS, FAChSHM, et al.
Published: (2016-03-01) -
Efficacy of Dapoxetine in the Treatment of Patients With Lifelong Premature Ejaculation as an Alternative to Sertraline Therapy
by: Guoxiong Liu, MD, et al.
Published: (2022-02-01) -
Efficacy of dapoxetine treatment in Chinese patients with premature ejaculation and possible factors affecting efficacy in the real-world practice
by: Jing Peng, et al.
Published: (2020-02-01) -
Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation
by: Abdulmuttalip Simsek, et al.
Published: (2014-10-01) -
A randomized controlled trial of combined low-intensity extracorporeal shockwave therapy and Dapoxetine use in the management of lifelong premature ejaculation
by: Kazim Dogan, et al.
Published: (2023-08-01)